Epi-Hypo: Survey on Epidemiology of Hypoparathyroidism in France
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 54
- 主要终点
- Assessment of the epidemiology of patients with hypoparathyroidism in France
研究概览
简要总结
Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.
详细描述
Very few data has been published on the epidemiology of hypoparathyroidism worldwide. None exists specifically in France. Hypoparathyroidism could led to complications: e.g. symptomatic hypocalcemia, calcifications (brain, eye and other soft tissues), nephrolithiasis/nephrocalcinosis, renal insufficiency. Here,the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patient fro whom chronic hypoparathyroidism is diagnosed
- •patient living in France
排除标准
- •patient who does not want his data to be collected in this registry
- •pseudo-hypoparathyroidism
- •acute hypoparathyroidism
结局指标
主要结局
Assessment of the epidemiology of patients with hypoparathyroidism in France
时间窗: Through study completion, about 2 years
Data collected by questionnaire about etiology of hypoparathyroidism, filled by physicians from clinic folders
次要结局
- Assessment of the biology (calcemia, calciuria, parathormone, creatininemia, phosphatemia & magnesemia) at diagnosis and drug therapy at inclusion will describe population(Through study completion, about 2 years)
- Assessment of the biology at inclusion will describe the evolution of the included population from diagnosis to now (inclusion)(At inclusion (under treatment): through study completion, about 2 years)
- Assessment of the management at inclusion will describe treatment and complications at inclusion(At inclusion (under treatment): through study completion, about 2 years)
研究者
Jean-philippe Bertocchio, MD, PhD
MD, PhD
European Georges Pompidou Hospital